14:57 IST
BSE
Board Meeting Outcome
Indo US Bio-Tech Board Meeting Outcome
Indo Us Bio-Tech Ltd announced outcomes of its board meeting, including the date for its 22nd AGM and appointment of statutory auditors.
Indo US Bio-Tech Ltd
- Share price
- ₹74.93
- Market cap
- ₹150.2 Cr
- Revenue (annual)
- ₹110.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 13.1×Sector 28.6×
- Promoter holding
- 68.29%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 7Financial Results 4Board Meeting Outcome 4Other Announcement 3Annual General Meeting 3Board Meeting Date 2Debt & Borrowing 1Annual Report 1
Time
4 announcements with these filters
16:24 IST
BSE
Board Meeting Outcome
Indo US Bio-Tech Board Meeting Outcome
Indo Us Bio-Tech announced a revised effective date for board committee reconstitutions. The changes reflect director appointments and resignations effective from April 21, 2026.
18:44 IST
BSE
Board Meeting Outcome
Indo US Bio-Tech Board Meeting Outcome
Indo Us Bio-Tech Ltd's board decided to seek shareholder approval for a new independent director and statutory auditor via postal ballot. The process is scheduled for July-August 2026.
16:04 IST
BSE
Board Meeting Outcome
Indo US Bio-Tech Board Meeting Outcome
Board noted resignations and approved appointments of statutory and internal auditors. Changes are effective from June 15-16, 2026, subject to shareholder approval.